Ionis Pharmaceuticals | Денежные Средства И Эквиваленты

Биржевая цена
80.60
Изменение за день
-1.18 -1.44%
Ежемесячно
2.19%
Ежегодный
159.66%
Q1 прогноз
78.10




Денежные средства и эквиваленты Изменить Дата
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
BioCryst Pharmaceuticals USD 84.08M 3.95M 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Celltrion KRW 29.65B 799.42B 2025-06
Cspc Pharmaceutical CNY 7.57B 793.73M 2025-06
Divis Laboratories Ltd INR 4.15B 31.87B 2025-03
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Halozyme Therapeutics USD 419.66M 357.8M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
Kangmei Pharma CNY 1.18B 278M 2025-09
Knight Therapeutics CAD 77.82M 34.34M 2025-06
Laboratorios Farma EUR 46.11M 18.92M 2025-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Medical Developments International AUD 17.84M 219K 2025-06
Moderna USD 2.6B 1.46B 2025-12
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
OPKO Health USD 411.97M 144.69M 2025-09
Organigram Holdings CAD 28.2M 7.68M 2025-09
Pfizer USD 1.34B 295M 2025-09
Pharma Mar EUR 21.59M 38.7M 2025-06
PTC Therapeutics USD 672.62M 344.77M 2025-09
Qiagen NV USD 1.36B 621.78M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Sartorius EUR 389.9M 429.1M 2025-09
Sino Biopharmaceutical CNY 3.38B 2.09B 2024-12
Tilray USD 264.83M 43.16M 2025-06
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12
Zz Pientze Pharmaceu CNY 1.77B 376.03M 2025-06


Ionis Pharmaceuticals Денежные Средства И Эквиваленты - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Feb 2026.